BPC‑157, a synthetic peptide derived from body
protection compound 157, has gained attention for its potential
regenerative and anti‑inflammatory effects across a wide range of tissues.
Researchers have investigated its use in muscle injuries, tendon ruptures,
ligament tears, nerve damage, and even gastrointestinal
disorders. Because the clinical data remain limited and regulatory approval is lacking in many jurisdictions, users typically rely on anecdotal reports and small‑scale studies to guide dosage and administration protocols.
BPC‑157 Peptide Dosage Explained (for Men & Women)
The recommended starting dose for most adult
users, regardless of gender, is 200 µg per day.
This quantity can be divided into two administrations—once in the morning and once in the evening—to maintain a steady serum level throughout the day.
Many practitioners advise beginning with this conservative
amount to assess tolerance before increasing.
For men who are engaging in high‑intensity training or recovering from significant
musculoskeletal trauma, a gradual escalation to 300 µg per day may be appropriate after at least one week
of stable response. Women often experience similar efficacy at the lower dose
range; however, those with higher body mass or more severe injury might consider
stepping up to 250–300 µg per day if tolerance allows.
It is essential to monitor for any adverse reactions,
such as flushing, headaches, or mild gastrointestinal
discomfort. If these occur, reducing the dose back to
200 µg and re‑evaluating after a week can help identify the optimal individual threshold.
TL;DR – BPC‑157 Dosage Amount
Start with 200 µg per day (split into two doses).
Increase cautiously: men up to 300 µg, women up to 250–300 µg if needed.
Adjust based on response and tolerance.
BPC‑157 Injection Dosage
The peptide is most commonly delivered subcutaneously or intramuscularly.
A typical injection protocol uses a sterile syringe with a fine gauge needle
(27–30 gauge) for subcutaneous injections, ensuring the
solution is mixed thoroughly before administration to prevent precipitation.
A standard regimen for injury recovery involves:
Daily Dose – 200 µg total per day.
- Morning: 100 µg subcutaneously in the abdomen or thigh.
- Evening: 100 µg intramuscularly into a large muscle such as the gluteus.
Duration – Continuous daily injections for 4–6 weeks, followed by a tapering phase of 1–2
weeks to allow the body’s natural healing
processes to consolidate gains.
Loading Phase (Optional) – Some users begin with a "loading" dose of 300 µg on the first day to
accelerate initial tissue repair, then revert to the
maintenance dose thereafter.
Adjunctive Measures – Pairing BPC‑157 injections with
adequate protein intake, rest periods, and
physical therapy enhances overall recovery outcomes. Avoid high‑dose
NSAIDs during treatment as they may interfere with the peptide’s anti‑inflammatory action.
Monitoring – Keep a log of injection sites, any local reactions, and subjective changes in pain or mobility.
If swelling or redness at the site persists beyond
48 hours, rotate to a new area or reduce dose temporarily.
By adhering to these guidelines, users can tailor BPC‑157 therapy to their
specific needs while minimizing potential risks.
